Androgen deprivation therapy and diet: what is the evidence?

Androgen deprivation therapy and diet: what is the evidence?

Prostate cancer is the most common cancer in men. With advances in medical therapy, more and more patients are being put on androgen deprivation therapy. Literature demonstrates men undergoing surgery for prostate cancer have significant unmet needs. However, as yet, no systematic review has examined diet and diabetes. Adult males (≥18, <55 years) AND Prostate cancer AND Androgen deprivation th...

androgen deprivation therapy and cardiovascular risk

Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?

The past decade has brought increased awareness of the potential adverse effects of androgen deprivation therapy (ADT) in men with prostate cancer. Arguably the most important and controversial of these is the increased risk of cardiovascular morbidity and mortality. Although multiple observational studies have shown that men treated with ADT are at increased risk of developing atherosclerotic ...

Androgen deprivation therapy.

© TouCh MEdiCal MEdia 2014 This review describes strategies for producing castrate levels of testosterone in men with androgen-sensitive prostate cancer (PC) and the associated toxicities, with particular focus on the re-emergence and potential benefits of parenteral estrogen. In the developed world, PC is the commonest malignancy and second commonest cause of cancer death affecting men. Its in...

Androgen deprivation therapy complications.

Androgen deprivation therapy (ADT) is increasingly used to treat advanced prostate cancer and is also utilised as adjuvant or neo-adjuvant treatment for high-risk disease. The resulting suppression of endogenous testosterone production has deleterious effects on quality of life, including hot flushes, reduced mood and cognition and diminished sexual function. Cross-sectional and longitudinal st...